Los Angeles Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $947K | Sell |
14,513
-4,410
| -23% | -$288K | ﹤0.01% | 658 |
|
|
2025
Q1 | $1.27M | Sell |
18,923
-651
| -3% | -$43.6K | 0.01% | 501 |
|
|
2024
Q4 | $1.08M | Sell |
19,574
-1,900
| -9% | -$105K | ﹤0.01% | 595 |
|
|
2024
Q3 | $1.28M | Sell |
21,474
-1,500
| -7% | -$89.5K | 0.01% | 562 |
|
|
2024
Q2 | $1.46M | Sell |
22,974
-2,000
| -8% | -$127K | 0.01% | 527 |
|
|
2024
Q1 | $1.73M | Buy |
24,974
+5,408
| +28% | +$374K | 0.01% | 535 |
|
|
2023
Q4 | $1.08M | Sell |
19,566
-129
| -0.7% | -$7.11K | ﹤0.01% | 652 |
|
|
2023
Q3 | $1.14M | Sell |
19,695
-13,209
| -40% | -$767K | ﹤0.01% | 600 |
|
|
2023
Q2 | $1.77M | Buy |
+32,904
| New | +$1.77M | 0.01% | 521 |
|